Table 3.
HR | 95% CI | P-value | |
---|---|---|---|
Unadjusted analysis | 3.10 | 1.26−7.32 | 0.015 |
Analysis adjusted for: | |||
Age and sex | 3.76 | 1.52−9.03 | 0.005 |
Age, sex, duration after diagnosis of AF, beta-blocker use before ablation, LAVI, BNP, Class III AAD use after ablation, and eGFR | 3.60 | 1.12−11.0 | 0.032 |
Age, sex, duration after diagnosis of AF, beta-blocker use before ablation, LAVI, BNP, Class III AAD use after ablation, and CKD stage | 3.67 | 1.13−11.7 | 0.031 |
AAD, anti-arrhythmic drug; AF, atrial fibrillation; BNP, B-type natriuretic peptide; CI, confidence interval; CKD, chronic kidney disease; eGFR, estimated glomerular filtration rate; HR, hazard ratio; LAVI, left atrial volume index.